Researcher
Yue Wang obtained his PhD from the University of Minnesota in 1988. In 1989, he joined IMCB as a Postdoctoral Research Fellow. He was promoted to Senior Scientist in 1993 to lead a group in the study and utilisation of equatorial microbial diversity to discover novel bioactive compounds. In 2010, he was promoted to Research Director, whose research revolves around studying the human fungal pathogen Candida albicans. On 01 April 2022, he joined A*STAR Infectious Diseases Labs as a Senior Principal Investigator to continue his research on fungal pathogens. For his outstanding research efforts, Wang was awarded the President’s Science Award in 2012.
Related Articles
Disarming a deadly yeast
23 Jan 2023Scientists discover a potential therapeutic target to tackle a dangerous drug-resistant yeast strain.
When antibiotics make good yeasts go bad
9 Nov 2021Broad-acting antibiotics can disrupt the gut microbiome and create the perfect conditions for potentially life-threatening
How bacteria influence host immunity
24 May 2019When parts of a bacteria's cell wall enter into circulation, its host experiences more severe